| Li, Yue |
NCT06292013: A Study to Investigate the Effect of Lepodisiran on the Reduction of Major Adverse Cardiovascular Events in Adults With Elevated Lipoprotein(a) - ACCLAIM-Lp(a) |
|
|
| Recruiting | 3 | 12500 | Europe, Canada, Japan, US, RoW | Lepodisiran Sodium, LY3819469, Placebo | Eli Lilly and Company | Atherosclerotic Cardiovascular Disease (ASCVD), Elevated Lp(a) | 03/29 | 03/29 | | |
TRAPP, NCT05811676: Tranexamic Acid for the Prevention of Postpartum Hemorrhage in Pregnant Women with Placenta Previa |
|
|
| Recruiting | 3 | 1680 | RoW | Tranexamic acid, 0.9% sodium chloride | Guangzhou Medical University, Dongguan Maternal and Child Health Care Hospital, Foshan Women and Children Hospital, BoAi Hospital of Zhongshan, Women and Children's Hospital of Chongqing Medical University, Tianjin Central Hospital of Gynecology Obstetrics, Shandong Provincial Maternal and Child Health Care Hospital Affiliated to Qingdao University, Jinan, Urumqi Maternal and Child Health Care Hospital, Zhuhai Women and Children's Hospital, The First Affiliated Hospital of Zhengzhou University, Hunan Provincial Maternal and Child Health Care Hospital, Dalian women and children's medical group, Nanfang Hospital, Southern Medical University, Huadu District People's Hospital of Guangzhou, Northwest Women's and Children's Hospital, Xi'an, Shaanxi, First Affiliated Hospital, Sun Yat-Sen University, Shenzhen Maternity & Child Healthcare Hospital, Shenzhen Baoan Women's and Children's Hospital, Dongguan People's Hospital, First Affiliated Hospital of Xinjiang Medical University, Tongji Hospital, Peking Union Medical College, Peking University First Hospital, The First Affiliated Hospital of Guangzhou Medical University, Second Affiliated Hospital of Guangzhou Medical University, Fifth Affiliated Hospital of Guangzhou Medical University, Shijiazhuang Obstetrics and Gynecology Hospital | Hemorrhage, Postpartum, Placenta Previa | 02/25 | 04/25 | | |
| Not yet recruiting | 3 | 8862 | RoW | Colchicine 0.5 mg, no other name, Colchicine 0.375 mg, Placebo | Wuhan Union Hospital, China | Coronary Heart Disease, Percutaneous Coronary Intervention, Colchicine | 03/28 | 08/28 | | |
NCT04222530: The Diagnosis of Invasive Depth of Early Rectal Cancer |
|
|
| Not yet recruiting | N/A | 81 | NA | Linear EUS first, ME-NBI first | Nanfang Hospital of Southern Medical University | Early Rectal Cancer | 06/22 | 12/22 | | |
| Recruiting | N/A | 100 | RoW | Dopamine, Fractional Flow Reserve, Renal, Renal artery stenting | Peking University First Hospital | Renal Artery Stenosis Atherosclerotic, Secondary Hypertension Renal Arterial | 03/25 | 03/25 | | |
NCT06394089: Effect of Degenerative Spondylolisthesis on the Clinical Outcome of Unilateral Biportal Endoscopy for Lumbar Spinal Stenosis: Study Protocol |
|
|
| Recruiting | N/A | 240 | RoW | | Beijing Friendship Hospital | Degenerative Spondylolisthesis, Lumbar Spinal Stenosis | 02/27 | 02/27 | | |
NCT06357026: Phitys I™ Percutaneous Left Ventricular Assist System Study |
|
|
| Not yet recruiting | N/A | 344 | RoW | Percutaneous Ventricular Assist System（Phigine Medical）, intra-aortic balloon pump (IABP) | Shanghai NewMed Medical Co., Ltd., Shanghai Phigine Medical Technology Co., Ltd. | Coronary Artery Disease | 05/25 | 04/26 | | |
NCT04493086: Effect of FFRCT-angio in Functional Diagnosis of Coronary Artery Stenosis |
|
|
| Recruiting | N/A | 500 | RoW | FFRCT-angio | First Affiliated Hospital of Harbin Medical University | Coronary Artery Disease | 10/21 | 12/21 | | |
NCT05191342: Proprotein Convertase Subtilisin Kexin 9 in Rheumatoid Arthritis |
|
|
| Recruiting | N/A | 75 | RoW | Enzyme-linked immunosorbent assay for PCSK9 | First Affiliated Hospital of Harbin Medical University | PCSK9 | 11/22 | 11/22 | | |
| Yu, Zhangbin |
NCT05115721: Establishing the Reference Interval for Pulse Oxygen Saturation in Neonates at High Altitude |
|
|
| Recruiting | N/A | 10000 | RoW | no intervention | Nanjing Medical University, Affiliated Hospital of Qinghai University, Qinghai Red Cross Hospital, Qinghai Women and Children's Hospital, Geermu People's Hospital, Yushu Prefecture People's Hospital, Guoluo Tibetan Autonomous Prefecture People's Hospital | High Altitude | 02/23 | 02/23 | | |
NCT05481866: Targeting Gut Microbiota and Metabolites for Very Preterm Infants Through Oropharyngeal Administration of Colostrum |
|
|
| Not yet recruiting | N/A | 320 | RoW | Oropharyngeal administration of colostrum, Oropharyngeal administration of sterile water | Shenzhen People's Hospital, Shenzhen Bao'an Maternal and Child Health Hospital, Longgang Maternal and Child Health Hospital, Shenzhen, Guangdong | Gut Microbiota, Metabolites | 10/23 | 10/23 | | |
| Li, Guozhong |
TQB2450-III-09, NCT04964479: A Clinical Study of TQB2450 Injection Combined With Anlotinib Hydrochloride Capsules Versus K Drug in the Treatment of First-line Non-small Cell Lung Cancer(NSCLC) |
|
|
| Recruiting | 3 | 375 | RoW | TQB2450 injection, Anlotinib Hydrochloride Capsules, Pembrolizumab injection, Placebo | Chia Tai Tianqing Pharmaceutical Group Co., Ltd. | Non Small Cell Lung Cancer | 12/22 | 03/23 | | |
NCT05092841: A Study to Assess the Efficacy and Safety of PXT3003 in Charcot-Marie-Tooth Type 1A |
|
|
| Completed | 3 | 176 | RoW | PXT3003, (RS)-baclofen, naltrexone hydrochloride and D-sorbitol oral fixed dose combination, PXT3003 placebo, liquid oral solution | Tasly GeneNet Pharmaceuticals Co., Ltd | Charcot-Marie-Tooth Type 1A | 03/24 | 03/24 | | |
| Fu, Lu |
SUMMIT, NCT04847557: A Study of Tirzepatide (LY3298176) in Participants With Heart Failure With Preserved Ejection Fraction (HFpEF) and Obesity: The Trial |
|
|
| Completed | 3 | 731 | US, RoW | Tirzepatide, LY3298176, Placebo | Eli Lilly and Company | Obesity, Heart Failure With Preserved Ejection Fraction (HFpEF) | 07/24 | 07/24 | | |
|
KRAKEN, NCT05563246: A Study of LY3473329 in Adult Participants With Elevated Lipoprotein(a) at High Risk for Cardiovascular Events |
|
|
| Completed | 2 | 233 | Europe, Japan, US, RoW | LY3473329, Placebo | Eli Lilly and Company | Lipoprotein Disorder | 03/24 | 03/24 | | |
| Kuang, Hongyu |
QWINT-2, NCT05362058: A Study of Insulin Efsitora Alfa (LY3209590) Compared to Degludec in Adults With Type 2 Diabetes Who Are Starting Basal Insulin for the First Time |
|
|
| Completed | 3 | 928 | Europe, Canada, Japan, US, RoW | Insulin Efsitora Alfa, LY3209590 and Basal Insulin-FC, Insulin Degludec | Eli Lilly and Company | Diabetes, Type 2 Diabetes | 04/24 | 04/24 | | |
| Completed | 3 | 257 | RoW | Tirzepatide, LY3298176, Placebo | Eli Lilly and Company | Diabetes Type 2, Diabetes Mellitus, Glucose Metabolism Disorders, Metabolic Disease, Endocrine System Diseases | 07/24 | 07/24 | | |
| Active, not recruiting | 3 | 15374 | Europe, Canada, Japan, US, RoW | Tirzepatide, LY3298176, Placebo | Eli Lilly and Company | Obesity, Overweight | 10/27 | 10/27 | | |
NCT06606509: The Survey of Treatment and Metabolic Status of Type 1 Diabetes Mellitus (T1DM). |
|
|
| Not yet recruiting | N/A | 1000 | RoW | Continuous Glucose Monitoring System (GX-01S) | Nanjing First Hospital, Nanjing Medical University | Type1 Diabetes Mellitus | 10/26 | 06/27 | | |
NCT05498974: China Diabetes Type 1 Study (CD1S) by China Alliance for Type 1 Diabetes |
|
|
| Recruiting | N/A | 20000 | RoW | Standard type 1 diabetes management model constructed by China Alliance for Type 1 Diabetes in each center | Second Xiangya Hospital of Central South University | Type1diabetes, Diabetes | 12/35 | 12/35 | | |
| Liu, Yuting |
NCT06318364: Postoperative Delirium in the Post-anesthesia Care Unit |
|
|
| Recruiting | N/A | 3320 | RoW | NO Intervention | Qin Zhang, National Natural Science Foundation of China | Delirium, Postoperative | 12/24 | 12/24 | | |
